113 related articles for article (PubMed ID: 3966925)
1. In vivo inactivation of formylglycinamidine ribonucleotide synthetase in rat hepatoma.
Elliott WL; Weber G
Biochem Pharmacol; 1985 Jan; 34(2):243-8. PubMed ID: 3966925
[TBL] [Abstract][Full Text] [Related]
2. In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma.
Aoki T; Sebolt J; Weber G
Biochem Pharmacol; 1982 Mar; 31(6):927-32. PubMed ID: 7082374
[TBL] [Abstract][Full Text] [Related]
3. Biochemical pharmacology of acivicin in rat hepatoma cells.
Lui MS; Kizaki H; Weber G
Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
[TBL] [Abstract][Full Text] [Related]
4. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
Denton JE; Lui MS; Aoki T; Sebolt J; Weber G
Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346
[TBL] [Abstract][Full Text] [Related]
5. Proliferation-linked increase in phosphoribosylformylglycinamidine synthetase activity (EC 6.3.5.3).
Elliott WL; Weber G
Cancer Res; 1984 Jun; 44(6):2430-4. PubMed ID: 6722784
[TBL] [Abstract][Full Text] [Related]
6. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
Weber G; Prajda N; Lui MS; Denton JE; Aoki T; Sebolt J; Zhen YS; Burt ME; Faderan MA; Reardon MA
Adv Enzyme Regul; 1982; 20():75-96. PubMed ID: 6180609
[TBL] [Abstract][Full Text] [Related]
7. Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.
Sebolt JS; Aoki T; Eble JN; Glover JL; Weber G
Biochem Pharmacol; 1985 Jan; 34(1):97-100. PubMed ID: 3966920
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of Crithidia fasciculata carbamoyl phosphate synthetase II by the antitumor drug acivicin.
Aoki T; Oya H
Mol Biochem Parasitol; 1987 Mar; 23(2):173-81. PubMed ID: 3574357
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
Jayaram HN; Ardalan B; Deas M; Johnson RK
Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
[TBL] [Abstract][Full Text] [Related]
10. Mechanism for acivicin inactivation of triad glutamine amidotransferases.
Chittur SV; Klem TJ; Shafer CM; Davisson VJ
Biochemistry; 2001 Jan; 40(4):876-87. PubMed ID: 11170408
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of formylglycinamidine synthetase.
Schendel FJ; Stubbe J
Biochemistry; 1986 Apr; 25(8):2256-64. PubMed ID: 2939878
[TBL] [Abstract][Full Text] [Related]
12. Inactivation by acivicin of rat brain CTP and GMP synthetases and depression of CTP and GTP concentrations.
Achleitner E; Lui MS; Weber G
Adv Enzyme Regul; 1985; 24():225-32. PubMed ID: 3835820
[TBL] [Abstract][Full Text] [Related]
13. The glutamine hydrolysis function of human GMP synthetase. Identification of an essential active site cysteine.
Nakamura J; Straub K; Wu J; Lou L
J Biol Chem; 1995 Oct; 270(40):23450-5. PubMed ID: 7559506
[TBL] [Abstract][Full Text] [Related]
14. Combined action of acivicin and D-galactosamine on pyrimidine nucleotide metabolism in hepatoma cells.
Leube K; Keppler DO
Biochem Pharmacol; 1983 Jun; 32(12):1865-9. PubMed ID: 6882463
[TBL] [Abstract][Full Text] [Related]
15. L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine.
Jayaram HN; Cooney DA; Ryan JA; Neil G; Dion RL; Bono VH
Cancer Chemother Rep; 1975; 59(3):481-91. PubMed ID: 1147
[TBL] [Abstract][Full Text] [Related]
16. Guanosine-5'-phosphate synthetase and guanosine-5'-phosphate kinase in rat hepatomas and kidney tumors.
Boritzki TJ; Jackson RC; Morris HP; Weber G
Biochim Biophys Acta; 1981 Mar; 658(1):102-10. PubMed ID: 6260205
[TBL] [Abstract][Full Text] [Related]
17. Formylglycinamide ribonucleotide synthetase from Escherichia coli: cloning, sequencing, overproduction, isolation, and characterization.
Schendel FJ; Mueller E; Stubbe J; Shiau A; Smith JM
Biochemistry; 1989 Mar; 28(6):2459-71. PubMed ID: 2659070
[TBL] [Abstract][Full Text] [Related]
18. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
[TBL] [Abstract][Full Text] [Related]
19. Regulatory properties and behavior of activity of carbamoyl phosphate synthetase II (glutamine-hydrolyzing) in normal and proliferating tissues.
Aoki T; Morris HP; Weber G
J Biol Chem; 1982 Jan; 257(1):432-8. PubMed ID: 7053379
[TBL] [Abstract][Full Text] [Related]
20. Acivicin inhibits Crithidia fasciculata growth in a serum-free medium and inactivates carbamoyl-phosphate synthetase II in vivo.
Aoki T; Oya H
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):391-6. PubMed ID: 2902999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
